EE04315B1 - 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid - Google Patents

6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid

Info

Publication number
EE04315B1
EE04315B1 EEP200000501A EEP200000501A EE04315B1 EE 04315 B1 EE04315 B1 EE 04315B1 EE P200000501 A EEP200000501 A EE P200000501A EE P200000501 A EEP200000501 A EE P200000501A EE 04315 B1 EE04315 B1 EE 04315B1
Authority
EE
Estonia
Prior art keywords
aminocyclohexyl
purines
disubstituted
trans
amino
Prior art date
Application number
EEP200000501A
Other languages
English (en)
Estonian (et)
Inventor
Ann Dumont Jennifer
Joseph Bitonti Alan
Roger Borcherding David
Paul Peet Norton
Randall Munson Harry
Wai-Kwok Shum Patrick
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of EE200000501A publication Critical patent/EE200000501A/xx
Publication of EE04315B1 publication Critical patent/EE04315B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000501A 1998-02-26 1999-02-18 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid EE04315B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26
PCT/US1999/003451 WO1999043676A2 (fr) 1998-02-26 1999-02-18 2-[trans-(4- aminocyclohexyl) amino]purines 6,9-disubstituees

Publications (2)

Publication Number Publication Date
EE200000501A EE200000501A (et) 2002-02-15
EE04315B1 true EE04315B1 (et) 2004-06-15

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000501A EE04315B1 (et) 1998-02-26 1999-02-18 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid

Country Status (31)

Country Link
EP (1) EP1056745B1 (fr)
JP (1) JP2002504553A (fr)
KR (1) KR100568658B1 (fr)
CN (1) CN1128149C (fr)
AP (1) AP1258A (fr)
AR (1) AR019822A1 (fr)
AT (1) ATE269332T1 (fr)
AU (1) AU748178B2 (fr)
BR (1) BR9908325A (fr)
CA (1) CA2320448C (fr)
CZ (1) CZ291604B6 (fr)
DE (1) DE69918062T2 (fr)
DK (1) DK1056745T3 (fr)
EE (1) EE04315B1 (fr)
ES (1) ES2219038T3 (fr)
HK (1) HK1030948A1 (fr)
HU (1) HUP0100931A3 (fr)
IL (2) IL138044A0 (fr)
NO (1) NO20004281L (fr)
NZ (1) NZ506234A (fr)
OA (1) OA11480A (fr)
PL (1) PL344021A1 (fr)
PT (1) PT1056745E (fr)
RU (1) RU2191777C2 (fr)
SI (1) SI1056745T1 (fr)
SK (1) SK12912000A3 (fr)
TR (1) TR200002482T2 (fr)
TW (1) TW541308B (fr)
UA (1) UA62996C2 (fr)
WO (1) WO1999043676A2 (fr)
ZA (1) ZA991548B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627633B2 (en) 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
CZ20022353A3 (cs) * 2000-01-07 2003-02-12 Universitaire Instelling Antwerpen Deriváty purinu, způsob jejich přípravy a jejich použití
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
MXPA02010222A (es) 2000-04-18 2003-05-23 Agouron Pharma Pirazoles para inhibir proteina cinasa.
JP2004505983A (ja) 2000-08-09 2004-02-26 アグーロン　ファーマシューティカルズ，インコーポレイテッド ピラゾール−チアゾール化合物、これらを含む医薬組成物、およびサイクリン依存性キナーゼの阻害のためのこれらの使用方法
WO2002016326A1 (fr) 2000-08-18 2002-02-28 Agouron Pharmaceuticals, Inc. Hydroxyimino-fluorenes heterocycliques et leur utilisation pour inhiber des proteines kinases
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
AU2002239388B2 (en) * 2000-10-31 2006-05-25 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
JP4381804B2 (ja) 2001-06-27 2009-12-09 サイクラセル リミテッド ２，６，９−置換プリン誘導体及び増殖性疾患の治療におけるその使用
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
JPWO2004069233A1 (ja) * 2003-02-04 2006-05-25 株式会社ヤクルト本社 乳癌耐性蛋白阻害剤
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
EP2007365A2 (fr) * 2006-03-30 2008-12-31 PTC Therapeutics, Inc. Méthodes de production d'une protéine fonctionnelle à partir d'un adn présentant une mutation non-sens et traitement des troubles associés
EP2209786B1 (fr) * 2007-10-05 2013-02-27 Verastem, Inc. Dérivés de purine substitués par pyrimidine
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
WO2013130461A1 (fr) 2012-02-29 2013-09-06 The Scripps Research Institute Inhibiteurs de dégradation de wee1
US9879014B2 (en) 2013-07-12 2018-01-30 Kyoto University Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
CA3199430A1 (fr) 2015-01-16 2016-07-21 The General Hospital Corporation Composes pour ameliorer l'epissage de l'arnm
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
WO2021016263A1 (fr) * 2019-07-21 2021-01-28 University Of Virginia Patent Foundation Compositions de liaison à la cystéine et leurs procédés d'utilisation
WO2024105159A1 (fr) * 2022-11-16 2024-05-23 University Of Zurich Ligands des lecteurs d'arn m6a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
CA2234609C (fr) * 1995-11-01 2006-11-28 Novartis Ag Derives de 2-amino-6-anilino-purine et procedes de preparation
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
EE200000501A (et) 2002-02-15
NO20004281L (no) 2000-10-18
UA62996C2 (en) 2004-01-15
AU3299099A (en) 1999-09-15
AP1258A (en) 2004-03-15
ATE269332T1 (de) 2004-07-15
SK12912000A3 (sk) 2001-08-06
WO1999043676A2 (fr) 1999-09-02
PL344021A1 (en) 2001-09-24
CZ291604B6 (cs) 2003-04-16
ZA991548B (en) 1999-08-26
AU748178B2 (en) 2002-05-30
KR100568658B1 (ko) 2006-04-07
SI1056745T1 (en) 2004-12-31
OA11480A (en) 2004-05-05
CA2320448A1 (fr) 1999-09-02
JP2002504553A (ja) 2002-02-12
TW541308B (en) 2003-07-11
WO1999043676A3 (fr) 1999-10-21
PT1056745E (pt) 2004-09-30
CA2320448C (fr) 2005-02-01
CZ20003106A3 (cs) 2000-12-13
DE69918062D1 (de) 2004-07-22
KR20010041315A (ko) 2001-05-15
AP2000001923A0 (en) 2000-09-30
BR9908325A (pt) 2000-11-07
ES2219038T3 (es) 2004-11-16
CN1291983A (zh) 2001-04-18
HUP0100931A2 (hu) 2002-04-29
TR200002482T2 (tr) 2002-10-21
NZ506234A (en) 2003-05-30
CN1128149C (zh) 2003-11-19
AR019822A1 (es) 2002-03-20
IL138044A (en) 2006-04-10
HUP0100931A3 (en) 2002-08-28
DK1056745T3 (da) 2004-10-25
RU2191777C2 (ru) 2002-10-27
DE69918062T2 (de) 2005-06-02
NO20004281D0 (no) 2000-08-25
EP1056745A2 (fr) 2000-12-06
EP1056745B1 (fr) 2004-06-16
IL138044A0 (en) 2001-10-31
HK1030948A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
EE200000489A (et) 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid
EE200000501A (et) 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT891978E (pt) Derivados de 5h-tiazolo (3,2-a) pirimidina
IS5118A (is) 2-amínó-6-(2-setinn-4-fenoxý)-setin-pýridín
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DK1149106T3 (da) 4,5-azolo-oxindoler
FR2778528B1 (fr) Balancier, element de cornadis, cornadis
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
PT1056744E (pt) 2-¬trans-(4-aminociclo-hexil)amino|purinas 6,9-dissubstituidas
NO982469D0 (no) Herbicide 3,5-Difluorpyridiner
ID26084A (id) Turunan-turunan amino antrasiklinon
PT887349E (pt) Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina
SI1056744T1 (en) 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino)purines
FI981421A (fi) Jatkopistokytkin

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20100218